Dietary sesamin is converted to enterolactone in humans

José L. Peñalvo (Corresponding Author), Satu-Maarit Heinonen, Anna-Marja Aura, Herman Adlercreutz

Research output: Contribution to journalArticleScientificpeer-review

132 Citations (Scopus)

Abstract

Sesamin, a major sesame seed lignan, has many biological actions. The specific mechanisms for most of these actions as well as the full metabolic pathway of sesamin in humans are unclear. Two experiments were carried out to determine whether postprandial plasma enterolactone is related to sesamin concentration in sesame seeds and whether enterolactone is the major product of the in vitro fermentation of sesamin. Four subjects (3 women, 1 man) were given a single dose of sesame seeds after they consumed a low-lignan diet for 1 wk. Blood was collected at baseline and at time intervals after intake and plasma was analyzed for plant and mammalian lignan concentrations. Additionally, pure sesamin standard was incubated in vitro with human fecal inoculum to mimic the fermentation process in human gut. We calculated individual pharmacokinetic variables and found high interindividual variation in the plasma plant lignan concentrations. The mammalian lignan appearance rate in plasma shows that sesamin is a major precursor of enterolactone in vivo. In the in vitro experiment, enterolactone was the major metabolite and 3 intermediates were identified, allowing the elucidation of sesamin metabolism in humans. Enterolactone was the major metabolite of sesamin both in vivo and in vitro. The abundance of sesamin in sesame seeds indicates that they are a major food source of enterolactone precursors.
Original languageEnglish
Pages (from-to)1056 - 1062
JournalJournal of Nutrition
Volume135
Issue number5
DOIs
Publication statusPublished - 2005
MoE publication typeA1 Journal article-refereed

Fingerprint

Lignans
Sesamum
Seeds
Fermentation
2,3-bis(3'-hydroxybenzyl)butyrolactone
sesamin
Metabolic Networks and Pathways
Pharmacokinetics
Diet
Food
In Vitro Techniques

Keywords

  • enterodiol
  • enterolactone
  • lignans
  • sesame seed
  • sesamin

Cite this

Peñalvo, J. L., Heinonen, S-M., Aura, A-M., & Adlercreutz, H. (2005). Dietary sesamin is converted to enterolactone in humans. Journal of Nutrition, 135(5), 1056 - 1062. https://doi.org/10.1093/jn/135.5.1056
Peñalvo, José L. ; Heinonen, Satu-Maarit ; Aura, Anna-Marja ; Adlercreutz, Herman. / Dietary sesamin is converted to enterolactone in humans. In: Journal of Nutrition. 2005 ; Vol. 135, No. 5. pp. 1056 - 1062.
@article{0f60305b74a94094bb9a6c39ffea3895,
title = "Dietary sesamin is converted to enterolactone in humans",
abstract = "Sesamin, a major sesame seed lignan, has many biological actions. The specific mechanisms for most of these actions as well as the full metabolic pathway of sesamin in humans are unclear. Two experiments were carried out to determine whether postprandial plasma enterolactone is related to sesamin concentration in sesame seeds and whether enterolactone is the major product of the in vitro fermentation of sesamin. Four subjects (3 women, 1 man) were given a single dose of sesame seeds after they consumed a low-lignan diet for 1 wk. Blood was collected at baseline and at time intervals after intake and plasma was analyzed for plant and mammalian lignan concentrations. Additionally, pure sesamin standard was incubated in vitro with human fecal inoculum to mimic the fermentation process in human gut. We calculated individual pharmacokinetic variables and found high interindividual variation in the plasma plant lignan concentrations. The mammalian lignan appearance rate in plasma shows that sesamin is a major precursor of enterolactone in vivo. In the in vitro experiment, enterolactone was the major metabolite and 3 intermediates were identified, allowing the elucidation of sesamin metabolism in humans. Enterolactone was the major metabolite of sesamin both in vivo and in vitro. The abundance of sesamin in sesame seeds indicates that they are a major food source of enterolactone precursors.",
keywords = "enterodiol, enterolactone, lignans, sesame seed, sesamin",
author = "Pe{\~n}alvo, {Jos{\'e} L.} and Satu-Maarit Heinonen and Anna-Marja Aura and Herman Adlercreutz",
year = "2005",
doi = "10.1093/jn/135.5.1056",
language = "English",
volume = "135",
pages = "1056 -- 1062",
journal = "Journal of Nutrition",
issn = "0022-3166",
number = "5",

}

Peñalvo, JL, Heinonen, S-M, Aura, A-M & Adlercreutz, H 2005, 'Dietary sesamin is converted to enterolactone in humans', Journal of Nutrition, vol. 135, no. 5, pp. 1056 - 1062. https://doi.org/10.1093/jn/135.5.1056

Dietary sesamin is converted to enterolactone in humans. / Peñalvo, José L. (Corresponding Author); Heinonen, Satu-Maarit; Aura, Anna-Marja; Adlercreutz, Herman.

In: Journal of Nutrition, Vol. 135, No. 5, 2005, p. 1056 - 1062.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Dietary sesamin is converted to enterolactone in humans

AU - Peñalvo, José L.

AU - Heinonen, Satu-Maarit

AU - Aura, Anna-Marja

AU - Adlercreutz, Herman

PY - 2005

Y1 - 2005

N2 - Sesamin, a major sesame seed lignan, has many biological actions. The specific mechanisms for most of these actions as well as the full metabolic pathway of sesamin in humans are unclear. Two experiments were carried out to determine whether postprandial plasma enterolactone is related to sesamin concentration in sesame seeds and whether enterolactone is the major product of the in vitro fermentation of sesamin. Four subjects (3 women, 1 man) were given a single dose of sesame seeds after they consumed a low-lignan diet for 1 wk. Blood was collected at baseline and at time intervals after intake and plasma was analyzed for plant and mammalian lignan concentrations. Additionally, pure sesamin standard was incubated in vitro with human fecal inoculum to mimic the fermentation process in human gut. We calculated individual pharmacokinetic variables and found high interindividual variation in the plasma plant lignan concentrations. The mammalian lignan appearance rate in plasma shows that sesamin is a major precursor of enterolactone in vivo. In the in vitro experiment, enterolactone was the major metabolite and 3 intermediates were identified, allowing the elucidation of sesamin metabolism in humans. Enterolactone was the major metabolite of sesamin both in vivo and in vitro. The abundance of sesamin in sesame seeds indicates that they are a major food source of enterolactone precursors.

AB - Sesamin, a major sesame seed lignan, has many biological actions. The specific mechanisms for most of these actions as well as the full metabolic pathway of sesamin in humans are unclear. Two experiments were carried out to determine whether postprandial plasma enterolactone is related to sesamin concentration in sesame seeds and whether enterolactone is the major product of the in vitro fermentation of sesamin. Four subjects (3 women, 1 man) were given a single dose of sesame seeds after they consumed a low-lignan diet for 1 wk. Blood was collected at baseline and at time intervals after intake and plasma was analyzed for plant and mammalian lignan concentrations. Additionally, pure sesamin standard was incubated in vitro with human fecal inoculum to mimic the fermentation process in human gut. We calculated individual pharmacokinetic variables and found high interindividual variation in the plasma plant lignan concentrations. The mammalian lignan appearance rate in plasma shows that sesamin is a major precursor of enterolactone in vivo. In the in vitro experiment, enterolactone was the major metabolite and 3 intermediates were identified, allowing the elucidation of sesamin metabolism in humans. Enterolactone was the major metabolite of sesamin both in vivo and in vitro. The abundance of sesamin in sesame seeds indicates that they are a major food source of enterolactone precursors.

KW - enterodiol

KW - enterolactone

KW - lignans

KW - sesame seed

KW - sesamin

U2 - 10.1093/jn/135.5.1056

DO - 10.1093/jn/135.5.1056

M3 - Article

VL - 135

SP - 1056

EP - 1062

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 5

ER -